Federal contractor profile
EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.
UEI CNPVCR8DK7M8CAGE 057Y1
Overview
- Legal name
- EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.
- Also known as
- EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC
- Registered location
- GAITHERSBURG, MD, USA
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- Latest award activity
- Aug 18, 2026
Read company summary
EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. is associated with UEI CNPVCR8DK7M8 and CAGE 057Y1 in public federal records. AcornBids currently links 4 prime awards totaling $2.4B in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Biological Product (except Diagnostic) Manufacturing; Research and Development in Biotechnology (except Nanobiotechnology). These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)). Its public SAM.gov registration lists GAITHERSBURG, MD, USA.
At a glance
Not available
Why this customer concentration
Detailed agency totals are not available in this stored profile.
Largest positive coded-agency total ÷ all positive coded-agency totals × 100
Missing data is shown as unavailable.
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Oct 8, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.
- Doing business as
- EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC
- UEI
- CNPVCR8DK7M8
- CAGE
- 057Y1
- Registered address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879, USA
- Registration status
- Active
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- SAM activation
- Oct 13, 2025
- Initial registration
- Mar 21, 2002
- Entity start
- Apr 16, 2003
- SAM updated
- Oct 13, 2025
- Registration expires
- Oct 9, 2026
- Fiscal year end
- Dec 31
- Place of incorporation
- DE, USA
Research brief
Source facts
Federal award analysis
Net transaction obligations by federal fiscal period.
Reported transaction obligations by federal fiscal period; includes deobligations. Missing transactions are not estimated. Coverage: 4 of 4 selected awards. Select a period to explore its awards.
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| HHSO100201600030CIGF::OT::IGF | Department of Health and Human Services | $1.4B | Sep 30, 2016 | Sep 29, 2026 |
| 75A50119C00071ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM) | Department of Health and Human Services | $857.6M | Aug 30, 2019 | Sep 30, 2026 |
| 75N98026P00379HIV BIOLOGICS MASTER FILE SUPPORT POP: 4/27/26 TO 3/31/27, EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG, INC. | Department of Health and Human Services | $11.2K | Apr 27, 2026 | Mar 31, 2027 |
| 75A50123C00037MEDICAL COUNTERMEASURES (MCM) THAT CAN BE DEPLOYED IN THE EVENT OF A FILOVIRUS OUTBREAK ARE A CRUCIAL COMPONENT TO THE UNITED STATES GOVERNMENT?S (USG?S) OUTBREAK RESPONSE PLAN… | Department of Health and Human Services | $118.6M | Jul 31, 2023 | Jul 29, 2033 |
Upcoming positioning windows
Modeled recompete windows are estimates, not announced solicitations or guarantees.
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Oct 13, 2025 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Mar 21, 2002 |
| Entity start | Apr 16, 2003 |
Registration classifications: Small Business. These are separate from the reported certificates above.
| Industry | Reported size status |
|---|---|
| 325412 — Pharmaceutical Preparation Manufacturing | Not reported |
| 541713 — Research and Development in Nanotechnology | Not reported |
| 541714 — Research and Development in Biotechnology (except Nanobiotechnology) | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| REBECCA HEATH | Government business | Contact method not published | SAM registration | Not available |
| ALEX KONEV | Alternate government business | Contact method not published | SAM registration | Not available |
| REBECCA HEATH | Electronic business | Contact method not published | SAM registration | Not available |
| ALEX KONEV | Alternate electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 325412 — Pharmaceutical Preparation Manufacturing
- 541713 — Research and Development in Nanotechnology
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
About EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.
What products and services appear in its federal awards?
Recorded award industries: 541711; 325414 — Biological Product (except Diagnostic) Manufacturing; 541714 — Research and Development in Biotechnology (except Nanobiotechnology).
Recorded products and services: AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH; 6515 — Medical and Surgical Instruments, Equipment, and Supplies; AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT.
Examples from recent award records:
These records describe federal award work, not every company capability. Review the award evidence.
Where is the company registered?
300 PROFESSIONAL DR, GAITHERSBURG, Maryland 20879, United States
Registered location from SAM.gov; award performance locations may differ.
What is its primary registered industry?
541714 — Research and Development in Biotechnology (except Nanobiotechnology).
Primary SAM.gov NAICS classification.
Which federal agencies are represented in its awards?
Department of Health and Human Services.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
Disclosed relationships only. Missing records do not establish that a contractor has no partners. Ambiguous parent award identifiers are excluded.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit